Founded in Genoa in 1915 by Edoardo Maragliano, the man who discovered the first tuberculosis vaccine, PIAM is an Italian pharmaceutical company that has developed its core business in specialist and ethically significant therapeutic areas with prescription drugs. Over time it has gained particular expertise in inherited metabolic diseases that led the company to be a leader in this field. In the 70s, PIAM pioneered a specialist nutritional line to support its pharmaceutical products. It is able to offer a complete response for patients with disorders requiring particular nutritional therapy, throughout every phase of their lives. Leadership in the IEMD industry in Italy and its overseas development, as well as in the nootropics market.